You are on page 1of 1

Completion Date 13-Oct-2022

Expiration Date 12-Oct-2025


Record ID 52063568

This is to certify that:

Nakanwagi Angella
Not valid for renewal of
certification through CME.
Has completed the following CITI Program course:

Good Clinical Practice Course for Clinical Trials Involving Drugs (ICH focus)
(Curriculum Group)
GCP for Clinical Trials with Investigational Drugs and Biologics (ICH Focus)
(Course Learner Group)
1 - GCP
(Stage)

Under requirements set by:

International AIDS Vaccine Initiative (IAVI)


101 NE 3rd Avenue, Suite 320
This GCP training contains all of the attested CITI Program modules from the GCP for Clinical Trials with Investigational Fort Lauderdale, FL 33301 US
Drugs and Biologics (ICH Focus) Version 2. This ICH E6 GCP Investigator Site Training meets the Minimum Criteria for ICH
GCP Investigator Site Personnel Training identified by TransCelerate BioPharma as necessary to enable mutual recognition www.citiprogram.org
of GCP training among trial sponsors.

Verify at www.citiprogram.org/verify/?w237d0511-53b9-406a-a723-8eb8833a6590-52063568

You might also like